EDGAR Filing Documents for 0001193125-15-004170

Form 8-K - Current report:

SEC Accession No. 0001193125-15-004170

Filing Date

2015-01-08

Accepted

2015-01-07 18:23:05

Documents

Period of Report

2015-01-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FROM 8-K	d846506d8k.htm	8-K	18272
2	EXHIBIT 1.1	d846506dex11.htm	EX-1.1	213776
3	EXHIBIT 5.1	d846506dex51.htm	EX-5.1	10743
4	EXHIBIT 99.1	d846506dex991.htm	EX-99.1	7059
5	GRAPHIC	g846506aryopharm-takedownex.jpg	GRAPHIC	5112
6	GRAPHIC	g846506newkaryopharm-takedo.jpg	GRAPHIC	13587
	Complete submission text file	0001193125-15-004170.txt		277126

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459

Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600

Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)